These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22505397)

  • 1. Relationship between pump speed and exercise capacity during HeartMate II left ventricular assist device support: influence of residual left ventricular function.
    Noor MR; Bowles C; Banner NR
    Eur J Heart Fail; 2012 Jun; 14(6):613-20. PubMed ID: 22505397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of increasing pump speed during exercise on peak oxygen uptake in heart failure patients supported with a continuous-flow left ventricular assist device. A double-blind randomized study.
    Jung MH; Hansen PB; Sander K; Olsen PS; Rossing K; Boesgaard S; Russell SD; Gustafsson F
    Eur J Heart Fail; 2014 Apr; 16(4):403-8. PubMed ID: 24464845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pump speed modulations and sub-maximal exercise tolerance in left ventricular assist device recipients: A double-blind, randomized trial.
    Jung MH; Houston B; Russell SD; Gustafsson F
    J Heart Lung Transplant; 2017 Jan; 36(1):36-41. PubMed ID: 27522486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiopulmonary Performance Among Heart Failure Patients Before and After Left Ventricular Assist Device Implantation.
    Buchanan C; Buchanan C; Riordan M; Byrd J; Schulte M; Kohrt WM; Ambardekar AV; Allen LA; Wolfel G; Lawley J; Levine BD; Cornwell WK
    JACC Heart Fail; 2024 Jan; 12(1):117-129. PubMed ID: 37632493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise capacity in left ventricular assist device patients with full and partial support.
    Fresiello L; Buys R; Jacobs S; Van Puyvelde J; Droogne W; Rega F; Meyns B
    Eur J Prev Cardiol; 2017 Jan; 24(2):168-177. PubMed ID: 27353127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of acute reduction of continuous-flow left ventricular assist device support on cardiac and exercise performance.
    Jakovljevic DG; George RS; Nunan D; Donovan G; Bougard RS; Yacoub MH; Birks EJ; Brodie DA
    Heart; 2010 Sep; 96(17):1390-5. PubMed ID: 20643664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices.
    Haft J; Armstrong W; Dyke DB; Aaronson KD; Koelling TM; Farrar DJ; Pagani FD
    Circulation; 2007 Sep; 116(11 Suppl):I8-15. PubMed ID: 17846330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central and peripheral blood flow during exercise with a continuous-flow left ventricular assist device: constant versus increasing pump speed: a pilot study.
    Brassard P; Jensen AS; Nordsborg N; Gustafsson F; Møller JE; Hassager C; Boesgaard S; Hansen PB; Olsen PS; Sander K; Secher NH; Madsen PL
    Circ Heart Fail; 2011 Sep; 4(5):554-60. PubMed ID: 21765126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
    J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise performance of chronic heart failure patients in the early period of support by an axial-flow left ventricular assist device as destination therapy.
    Compostella L; Russo N; Setzu T; Compostella C; Bellotto F
    Artif Organs; 2014 May; 38(5):366-73. PubMed ID: 24117945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of Improvement in Cardiopulmonary Exercise Testing After Left Ventricular Assist Device Implantation.
    Rosenbaum AN; Dunlay SM; Pereira NL; Allison TG; Maltais S; Stulak JM; Joyce LD; Kushwaha SS
    ASAIO J; 2018; 64(5):610-615. PubMed ID: 29045277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise hemodynamics during extended continuous flow left ventricular assist device support: the response of systemic cardiovascular parameters and pump performance.
    Martina J; de Jonge N; Rutten M; Kirkels JH; Klöpping C; Rodermans B; Sukkel E; Hulstein N; Mol B; Lahpor J
    Artif Organs; 2013 Sep; 37(9):754-62. PubMed ID: 24074245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D Morphological Changes in LV and RV During LVAD Ramp Studies.
    Addetia K; Uriel N; Maffessanti F; Sayer G; Adatya S; Kim GH; Sarswat N; Fedson S; Medvedofsky D; Kruse E; Collins K; Rodgers D; Ota T; Jeevanandam V; Mor-Avi V; Burkhoff D; Lang RM
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):159-169. PubMed ID: 28412431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual native left ventricular function optimization using quantitative 3D echocardiographic assessment of rotational mechanics in patients with left ventricular assist devices.
    Medvedofsky D; Mor-Avi V; Sayer G; Addetia K; Kruse E; Adatya S; Kim G; Weinert L; Yamat M; Ota T; Jeevanandam V; Uriel N; Lang RM
    Echocardiography; 2018 Oct; 35(10):1606-1615. PubMed ID: 30044511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurohormonal activation and exercise tolerance in patients supported with a continuous-flow left ventricular assist device.
    Jung MH; Goetze JP; Boesgaard S; Gustafsson F
    Int J Cardiol; 2016 Oct; 220():196-200. PubMed ID: 27379923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and haemodynamic recovery after implantation of continuous-flow left ventricular assist devices in comparison with pulsatile left ventricular assist devices in patients with end-stage heart failure.
    Pruijsten RV; Lok SI; Kirkels HH; Klöpping C; Lahpor JR; de Jonge N
    Eur J Heart Fail; 2012 Mar; 14(3):319-25. PubMed ID: 22294758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro hemodynamic characterization of HeartMate II at 6000 rpm: Implications for weaning and recovery.
    Sunagawa G; Byram N; Karimov JH; Horvath DJ; Moazami N; Starling RC; Fukamachi K
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):343-8. PubMed ID: 26204865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronotropic incompetence and abnormal heart rate recovery early after left ventricular assist device implantation.
    Dimopoulos S; Diakos N; Tseliou E; Tasoulis A; Mpouchla A; Manetos C; Katsaros L; Drakos S; Terrovitis J; Nanas S
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1607-14. PubMed ID: 21950763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiographic Changes in Patients Implanted With a Fully Magnetically Levitated Left Ventricular Assist Device (Heartmate 3).
    Uriel N; Medvedofsky D; Imamura T; Maly J; Kruse E; Ivák P; Sood P; Lang RM; Maffessanti F; Berliner D; Bauersachs J; Haverich A; Želízko M; Netuka I; Schmitto JD
    J Card Fail; 2019 Jan; 25(1):36-43. PubMed ID: 30472281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.